Dare Bioscience Inc Share Price Today: Live Updates & Key Insights

Dare Bioscience Inc share price today is $1.36, up 4.62%. The stock opened at $1.32 against the previous close of $1.3, with an intraday high of $1.335 and low of $1.27.

Dare Bioscience Inc Share Price Chart

Dare Bioscience Inc

us-stock
To Invest in {{usstockname}}
us-stock

Dare Bioscience Inc Share Price Performance

$1.36 0.0462(4.62%) DARE at 23 Mar 2026 12:38 PM Biotechnology
Lowest Today 1.27
Highest Today 1.335
Today’s Open 1.32
Prev. Close 1.3
52 Week High 3.28
52 Week Low 1.27
Day’s Range: Low 1.27 High 1.335
52-Week Range: Low 1.27 High 3.28
1 day return -
1 Week return -11.72
1 month return -22.42
3 month return -40.46
6 month return -37.56
1 year return -55.55
3 year return +25.49
5 year return -35.02
10 year return -

Dare Bioscience Inc Institutional Holdings

Vanguard Group Inc 3.66

Vanguard Total Stock Mkt Idx Inv 1.74

AMH Equity Ltd 1.63

Vanguard Institutional Extnd Mkt Idx Tr 1.50

Geode Capital Management, LLC 0.83

Fidelity Extended Market Index 0.52

Susquehanna International Group, LLP 0.49

Two Sigma Investments LLC 0.23

State Street Corp 0.16

UBS Group AG 0.16

Renaissance Technologies Corp 0.14

Two Sigma Advisers, LLC 0.13

Virtu Financial LLC 0.12

BlackRock Inc 0.12

Blackrock Extended Mkt Fund CF 0.11

Fidelity Total Market Index 0.11

Northern Trust Corp 0.10

LPL Financial Corp 0.10

Extended Equity Market Fund K 0.10

Fidelity Series Total Market Index 0.08

Objectivity Squared LLC 0.08

Jane Street Group LLC 0.07

HRT FINANCIAL LLC 0.07

T. Rowe Price Associates, Inc. 0.07

T. Rowe Price U.S. Equities Tr 0.07

Spartan Total Market Index Pool G 0.07

Northern Trust Extended Eq Market Idx 0.06

NT Ext Equity Mkt Idx Fd - L 0.06

Fidelity Nasdaq Composite Index 0.05

NT Ext Equity Mkt Idx Fd - NL 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

State St US Extended Mkt Indx NL Cl C 0.03

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.02

Vanguard U.S. Eq Idx £ Acc 0.02

Parallel Advisors, LLC 0.02

Extended Equity Market Fund M 0.01

SSgA U.S. Total Market Index Strategy 0.01

BNYM Mellon SL Market Completion UC1 0.01

IFS Advisors, LLC 0.01

SBI Securities Co Ltd 0.00

Dare Bioscience Inc Market Status

Strong Buy: 2

Buy: 1

Hold: 1

Sell: 0

Strong Sell: 0

Dare Bioscience Inc Fundamentals

Market Cap 18.33 M

PB Ratio 6.7999

PE Ratio 0.0

Enterprise Value -0.71 M

Total Assets 22.10 M

Volume 204820

Dare Bioscience Inc Company Financials

Annual Revenue FY23:1000000 1.0M, FY22:10000000 10.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:10000000 10.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-41047052 -41.0M, FY22:406802262 406.8M, FY21:-38326218 -38.3M, FY20:-27400743 -27.4M, FY19:-14263830 -14.3M

Quarterly Revenue Q3/2025:2262 0.0M, Q2/2025:-21172 -0.0M, Q1/2025:25427 0.0M, Q3/2024:41691 0.0M, Q2/2024:22438 0.0M

Quarterly Profit Q3/2025:-610602 -0.6M, Q2/2025:-21172 -0.0M, Q1/2025:-2271954 -2.3M, Q3/2024:41691 0.0M, Q2/2024:-2562 -0.0M

Quarterly Net worth Q3/2025:-3562766 -3.6M, Q2/2025:-4016483 -4.0M, Q1/2025:-4378307 -4.4M, Q3/2024:-4702501 -4.7M, Q2/2024:12910656 12.9M

About Dare Bioscience Inc & investment objective

Company Information Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Daré Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.

Organisation Biotechnology

Employees 21

Industry Biotechnology

CEO Ms. Sabrina Martucci Johnson

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Dare Bioscience Inc FAQs

What is the share price of Dare Bioscience Inc today?

The current share price of Dare Bioscience Inc is $1.36.

Can I buy Dare Bioscience Inc shares in India?

Yes, Indian investors can buy Dare Bioscience Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Dare Bioscience Inc shares in India?

You can easily invest in Dare Bioscience Inc shares from India by:

Can I buy fractional shares of Dare Bioscience Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Dare Bioscience Inc?

Dare Bioscience Inc has a market cap of $18.33 M.

In which sector does Dare Bioscience Inc belong?

Dare Bioscience Inc operates in the Biotechnology sector.

What documents are required to invest in Dare Bioscience Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Dare Bioscience Inc?

The PE ratio of Dare Bioscience Inc is N/A and the PB ratio is 6.80.